1. Balkwill, F., Lee, A., Aldam, G., Moodie, E., Thomas, J.A., Tavernier, J., Fiers, W.: Human tumor xenografts treated with human TNF alone or in combination with IF. Cancer Res.46:3990, 1986
2. Balkwill, F., Ward, B.G., Moodie, E., Fiers W.: Therapeutic potential of tumour necrosis factor alpha and gamma interferon in experimental human ovarian cancer. Cancer Res.47:4755, 1987
3. Tracey, K., Beutler, B., Lowry, S., Merryweather, J., Wolpe, S., Milsark, I., Hariri, R., Fahey, T., Zentella, A., Albert, J., Shires, T., Cerami, A.: Shock and tissue injury induced by recombinant human cachectin. Science234:470, 1986
4. Tracey, K., Fong, Y., Hesse, D., Manogue, K.R., Lee, A.T., Duo, G.C., Lowry, S.F., Cerami, A.: Anti-cachectin/TNF antibodies prevent septic shock during lethal bacteremia. Nature330:662, 1987
5. Abbruzzese, J., Levin, B., Ajani, J., Faintuch, J.S., Saks, S., Patt, Y.Z., Edwards, C., Ende, KI, Gutterman, J.U.: Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer. Cancer Res.49:4057, 1989